Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events

Back

ESC Premium Access

Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events

Session: What's new in hereditary dyslipidaemia?

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Doctor H. Phillips (Shrewsbury, GB)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Helen Phillips

Shrewsbury (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

Antioxidant property of high-density lipoprotein predicts the presence of atherosclerotic cardiovascular disease and corneal arcus in patients with familial hypercholesterolemia

Speaker: Doctor M. Ogura (Urayasu, JP)

Lp(a) levels predict cardiovascular events in patients with Familial Hypercholesterolemia but not in unaffected relatives. SAFEHEART registry results.

Speaker: Doctor L. Perez De Isla (Madrid, ES)

Access

Abstract

Slides

Familial hypercholesterolaemia diagnosis: a case of missed opportunity

Speaker: Professor K. Ray (London, GB)

Whole exome sequencing in primary severe hypertriglyceridemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Prevalence, clinical features, and prognosis of patients with extremely low high-density lipoprotein cholesterol

Speaker: Doctor H. Tada (Kanazawa, JP)

Access the full session

What's new in hereditary dyslipidaemia?

Speakers: Doctor H. Phillips, Doctor M. Ogura, Doctor L. Perez De Isla, Professor K. Ray, Doctor H. Tada...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources